Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT

Item Type:	Article
Title:	Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT
Creators Name:	Yde, C.W. and Frogne, T. and Lykkesfeldt, A.E. and Fichtner, I. and Issinger, O.G. and Stenvang, J.
Abstract:	Protein kinase CK2 is involved in cell proliferation and survival, and found overexpressed in virtually all types of human cancer, including breast cancer. We demonstrate that inhibition of CK2 with 2-dimethylamino-4,5,6,7-tetrabromo-benzimidazole (DMAT), a potent and specific CK2 inhibitor, results in caspase-mediated killing of human breast cancer cells with acquired resistance to antiestrogens, while DMAT fails to kill parental MCF-7 cells. The antiestrogen resistant breast cancer cells express reduced levels of Bcl-2 compared to MCF-7 cells. Reduced Bcl-2 protein level is also found in a tamoxifen resistant human breast tumor grown as a xenograft. We show that re-expression of Bcl-2 partially rescues antiestrogen resistant MCF-7 sublines from DMAT-induced cell death. In summary, our data suggest a novel role of CK2 in antiestrogen resistance.
Keywords:	CK2, DMAT, Breast Cancer, Antiestrogen Resistance, Apoptosis, Bcl-2
Source:	Cancer Letters
ISSN:	0304-3835
Publisher:	Elsevier
Volume:	256
Number:	2
Page Range:	229-237
Date:	28 October 2007
Official Publication:	https://doi.org/10.1016/j.canlet.2007.06.010
PubMed:	View item in PubMed

Repository Staff Only: item control page